A double-blind, placebo-controlled, multicentre trial, gave a clear and powerful response with a proof of efficacy that was comparable to that obtainable by the running of two independent positive clinical trials.
Cardinal Systems has been supporting France Biotech since 2001, and works closely with governmental institutions implicated in the valorisation of innovation, such as Oseo, Comite Richelieu (Pactepme) and Medicen.
Cardinal Systems participates actively in working groups, such as DIA, PSI and CDISC.
Monitoring and Project Management
Cardinal Systems - Bio International Convention - May 4-6, 2010 @ Chicago
